Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)

BACKGROUND: Patients with ankylosing spondylitis (AS) are at increased risk of depression. This increased risk has been hypothesized to be solely secondary due to AS-related symptoms, or additionally due to a common inflammatory pathway. From a clinical perspective, it is important to know whether t...

Descripción completa

Detalles Bibliográficos
Autores principales: Webers, Casper, Stolwijk, Carmen, Schiepers, Olga, Schoonbrood, Thea, van Tubergen, Astrid, Landewé, Robert, van der Heijde, Désirée, Boonen, Annelies
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523309/
https://www.ncbi.nlm.nih.gov/pubmed/32993799
http://dx.doi.org/10.1186/s13075-020-02305-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523309/
https://www.ncbi.nlm.nih.gov/pubmed/32993799
http://dx.doi.org/10.1186/s13075-020-02305-w

Ejemplares similares